Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GRPEL2 pseudogene 1 is a non-protein-coding genomic sequence homologous to the functional GRPEL2 gene but contains mutations or deletions that prevent it from encoding a functional protein. Pseudogenes like GRPEL2P1 are often remnants of duplicated or retrotransposed genes. While some pseudogenes have been found to regulate gene expression (for instance, by acting as molecular decoys for microRNAs), there is no published data directly attributing such a function to GRPEL2 pseudogene 1. Furthermore, there is no evidence that GRPEL2P1 is a receptor, enzyme, transporter, or otherwise a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GRPEL2 pseudogene 1 (GRPEL2P1).